Earl W. Davie Symposium draws record attendance — including a Nobel Laureate
Ed Conway, Director of the Centre for Blood Research, greets the namesake of the symposium, now in its sixth year.
Transporting hypothermia victims to advanced heart and lung care facilities “worth the trip”
Doug Brown, a UBC emergency medicine resident, is the lead author of the article in the New England Journal of Medicine.
Faculty of Medicine celebrates 10 years of recruiting and supporting Aboriginal Students
The growing contingent of Aboriginal MD students includes Todd Alec, Nathan Teegee and Lara DesRoches.
New drug target found for cystic fibrosis lung disease
A team led by Stuart Turvey, an Associate Professor of Pediatrics, has discovered the cellular pathway that causes lung‐damaging inflammation in cystic fibrosis (CF), and found that reducing the pathway’s activity also decreases inflammation. The finding offers a potential new drug target for treating this form of lung disease, which is a major cause of illness and death […]
UBC effort to save pregnant women awarded additional $17 million
Prof. Peter von Dadelszen is leading the project, funded by the Bill & Melinda Gates Foundation, to diagnose and treat pre-eclampsia.
UBC spin-off company ready to launch phone-based pulse oximeter
The technology was developed by Mark Ansermino (left), in the Faculty of Medicine, and Guy Dumont, in Applied Science.
Terry Fox Foundation supports UBC research into aggressive leukemia
A team led by R. Keith Humphries, a Professor in the Division of Hematology, will receive $5.9 million over five years from the Terry Fox Foundation (TFF) to find new ways to treat aggressive forms of leukemia by rapidly creating and using laboratory-built models that mimic human acute leukemias. Dr. Humphries, the Director of the […]
A new leader for B.C. heart research and care
Dr. Andrew Krahn, an expert on inherited arrhythmias, was welcomed as the new Head of the Division of Cardiology.
Genes and immune system shaped by childhood poverty, stress
Research led by Michael Kobor, Associate Professor of Medical Genetics, examined a process called DNA methylation.
Some MS patients experience “natural” improvements in disability: UBC-VCH research
Prof. Helen Tremlett led the first study to quantify improvements in patients who are not taking immunomodulatory drugs.